These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 7742453

  • 1. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
    Tebas P, Sultan F, Wallace RJ, Fraser V.
    Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
    Wallace RJ, Tanner D, Brennan PJ, Brown BA.
    Ann Intern Med; 1993 Sep 15; 119(6):482-6. PubMed ID: 8357113
    [Abstract] [Full Text] [Related]

  • 4. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review.
    Vemulapalli RK, Cantey JR, Steed LL, Knapp TL, Thielman NM.
    J Infect; 2001 Oct 15; 43(3):163-8. PubMed ID: 11798252
    [Abstract] [Full Text] [Related]

  • 5. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Parize P, Hamelin A, Veziris N, Morand PC, Guillemain R, Lortholary O, Dupin N.
    J Eur Acad Dermatol Venereol; 2016 Jan 15; 30(1):101-5. PubMed ID: 25677464
    [Abstract] [Full Text] [Related]

  • 6. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug 15; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 7. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
    Wallace RJ, Brown BA, Onyi GO.
    J Infect Dis; 1992 Aug 15; 166(2):405-12. PubMed ID: 1386098
    [Abstract] [Full Text] [Related]

  • 8. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
    Driscoll MS, Tyring SK.
    J Am Acad Dermatol; 1997 Mar 15; 36(3 Pt 1):495-6. PubMed ID: 9091495
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ.
    J Clin Microbiol; 1999 Jun 15; 37(6):1676-82. PubMed ID: 10325306
    [Abstract] [Full Text] [Related]

  • 11. Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.
    Ichihara A, Jinnin M, Fukushima S, Inoue Y, Ihn H.
    J Dermatol; 2014 May 15; 41(5):414-7. PubMed ID: 24801916
    [Abstract] [Full Text] [Related]

  • 12. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
    Cremades R, Santos A, Rodríguez JC, Garcia-Pachon E, Ruiz M, Royo G.
    J Chemother; 2008 Feb 15; 20(1):43-7. PubMed ID: 18343742
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
    Chung WK, Kim MS, Kim CH, Lee MW, Choi JH, Moon KC, Koh JK.
    Acta Derm Venereol; 2009 Nov 15; 89(6):663-4. PubMed ID: 19997711
    [No Abstract] [Full Text] [Related]

  • 14. Disseminated cutaneous Mycobacterium chelonae infection.
    Kane CL, Vincent AL, Greene JN, Sandin RL.
    Cancer Control; 2000 Nov 15; 7(2):181-4. PubMed ID: 10783823
    [No Abstract] [Full Text] [Related]

  • 15. Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.
    Little JS, Dedrick RM, Freeman KG, Cristinziano M, Smith BE, Benson CA, Jhaveri TA, Baden LR, Solomon DA, Hatfull GF.
    Nat Commun; 2022 May 03; 13(1):2313. PubMed ID: 35504908
    [Abstract] [Full Text] [Related]

  • 16. Mycobacterium chelonae infection involving the auricle.
    Lin YH, Liu TC.
    QJM; 2012 Oct 03; 105(10):1021-2. PubMed ID: 21908384
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.
    Kullavanijaya P, Rattana-Apiromyakij N, Sukonthapirom-Napattalung P, Sirimachand S, Duangdeeden I.
    J Dermatol; 2003 Jun 03; 30(6):485-91. PubMed ID: 12810998
    [Abstract] [Full Text] [Related]

  • 19. [Development of subcutaneous nodules after mesotherapy].
    Ramos A, Roustan G, Lucena JL, Daza RM.
    Enferm Infecc Microbiol Clin; 2011 Dec 03; 29(10):775-7. PubMed ID: 21722998
    [No Abstract] [Full Text] [Related]

  • 20. Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
    Halpern J, Biswas A, Cadwgan A, Tan BB.
    Clin Exp Dermatol; 2010 Apr 03; 35(3):269-71. PubMed ID: 20500199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.